Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway

Oral cancer is a fatal disease, and its incidence in Taiwan is increasing. Thyroid hormone as L-thyroxine (T<sub>4</sub>) stimulates cancer cell proliferation via a receptor on integrin αvβ3 of plasma membranes. It also induces the expression of programmed death-ligand 1 (PD-L1) and cell...

Full description

Bibliographic Details
Main Authors: Kuan-Wei Su, Hung-Yun Lin, Hsien-Chung Chiu, Shin-Yu Shen, Chun A. ChangOu, Dana R. Crawford, Yu-Chen S. H. Yang, Ya-Jung Shih, Zi-Lin Li, Haw-Ming Huang, Jaqueline Whang-Peng, Yih Ho, Kuan Wang
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/19/3050
_version_ 1797480020806991872
author Kuan-Wei Su
Hung-Yun Lin
Hsien-Chung Chiu
Shin-Yu Shen
Chun A. ChangOu
Dana R. Crawford
Yu-Chen S. H. Yang
Ya-Jung Shih
Zi-Lin Li
Haw-Ming Huang
Jaqueline Whang-Peng
Yih Ho
Kuan Wang
author_facet Kuan-Wei Su
Hung-Yun Lin
Hsien-Chung Chiu
Shin-Yu Shen
Chun A. ChangOu
Dana R. Crawford
Yu-Chen S. H. Yang
Ya-Jung Shih
Zi-Lin Li
Haw-Ming Huang
Jaqueline Whang-Peng
Yih Ho
Kuan Wang
author_sort Kuan-Wei Su
collection DOAJ
description Oral cancer is a fatal disease, and its incidence in Taiwan is increasing. Thyroid hormone as L-thyroxine (T<sub>4</sub>) stimulates cancer cell proliferation via a receptor on integrin αvβ3 of plasma membranes. It also induces the expression of programmed death-ligand 1 (PD-L1) and cell proliferation in cancer cells. Thyroid hormone also activates β-catenin-dependent cell proliferation in cancer cells. However, the relationship between PD-L1 and cancer proliferation is not fully understood. In the current study, we investigated the role of inducible thyroid hormone-induced PD-L1-regulated gene expression and proliferation in oral cancer cells. Thyroxine bound to integrin αvβ3 to induce PD-L1 expressions via activation of ERK1/2 and signal transducer and activator of transcription 3 (STAT3). Inactivated STAT3 inhibited PD-L1 expression and nuclear PD-L1 accumulation. Inhibition of PD-L1 expression reduced β-catenin accumulation. Furthermore, nuclear PD-L1 formed a complex with nuclear proteins such as p300. Suppression PD-L1 expression by shRNA blocked not only expression of PD-L1 and β-catenin but also signal transduction, proliferative gene expressions, and cancer cell growth. In summary, thyroxine via integrin αvβ3 activated ERK1/2 and STAT3 to stimulate the PD-L1-dependent and β-catenin-related growth in oral cancer cells.
first_indexed 2024-03-09T21:54:08Z
format Article
id doaj.art-c64f343599974917a6dd74258222602d
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T21:54:08Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-c64f343599974917a6dd74258222602d2023-11-23T20:01:48ZengMDPI AGCells2073-44092022-09-011119305010.3390/cells11193050Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling PathwayKuan-Wei Su0Hung-Yun Lin1Hsien-Chung Chiu2Shin-Yu Shen3Chun A. ChangOu4Dana R. Crawford5Yu-Chen S. H. Yang6Ya-Jung Shih7Zi-Lin Li8Haw-Ming Huang9Jaqueline Whang-Peng10Yih Ho11Kuan Wang12Department of Dentistry, Hsinchu MacKay Memorial Hospital, Hsinchu City 30071, TaiwanGraduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanDepartment of Periodontology, School of Dentistry, National Defense Medical Center and Tri-Service General Hospital, Taipei 11490, TaiwanGraduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanCore Facility, Taipei Medical University, Taipei 11031, TaiwanDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USAJoint Biobank, Office of Human Research, Taipei Medical University, Taipei 11031, TaiwanGraduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanGraduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 11031, TaiwanCancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11031, TaiwanSchool of Pharmacy, Taipei Medical University, Taipei 11031, TaiwanGraduate Institute of Nanomedicine and Medical Engineering, College of Medical Engineering, Taipei Medical University, Taipei 11031, TaiwanOral cancer is a fatal disease, and its incidence in Taiwan is increasing. Thyroid hormone as L-thyroxine (T<sub>4</sub>) stimulates cancer cell proliferation via a receptor on integrin αvβ3 of plasma membranes. It also induces the expression of programmed death-ligand 1 (PD-L1) and cell proliferation in cancer cells. Thyroid hormone also activates β-catenin-dependent cell proliferation in cancer cells. However, the relationship between PD-L1 and cancer proliferation is not fully understood. In the current study, we investigated the role of inducible thyroid hormone-induced PD-L1-regulated gene expression and proliferation in oral cancer cells. Thyroxine bound to integrin αvβ3 to induce PD-L1 expressions via activation of ERK1/2 and signal transducer and activator of transcription 3 (STAT3). Inactivated STAT3 inhibited PD-L1 expression and nuclear PD-L1 accumulation. Inhibition of PD-L1 expression reduced β-catenin accumulation. Furthermore, nuclear PD-L1 formed a complex with nuclear proteins such as p300. Suppression PD-L1 expression by shRNA blocked not only expression of PD-L1 and β-catenin but also signal transduction, proliferative gene expressions, and cancer cell growth. In summary, thyroxine via integrin αvβ3 activated ERK1/2 and STAT3 to stimulate the PD-L1-dependent and β-catenin-related growth in oral cancer cells.https://www.mdpi.com/2073-4409/11/19/3050thyroxineoral cancerPD-L1β-catenin
spellingShingle Kuan-Wei Su
Hung-Yun Lin
Hsien-Chung Chiu
Shin-Yu Shen
Chun A. ChangOu
Dana R. Crawford
Yu-Chen S. H. Yang
Ya-Jung Shih
Zi-Lin Li
Haw-Ming Huang
Jaqueline Whang-Peng
Yih Ho
Kuan Wang
Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway
Cells
thyroxine
oral cancer
PD-L1
β-catenin
title Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway
title_full Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway
title_fullStr Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway
title_full_unstemmed Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway
title_short Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway
title_sort thyroid hormone induces oral cancer growth via the pd l1 dependent signaling pathway
topic thyroxine
oral cancer
PD-L1
β-catenin
url https://www.mdpi.com/2073-4409/11/19/3050
work_keys_str_mv AT kuanweisu thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT hungyunlin thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT hsienchungchiu thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT shinyushen thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT chunachangou thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT danarcrawford thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT yuchenshyang thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT yajungshih thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT zilinli thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT hawminghuang thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT jaquelinewhangpeng thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT yihho thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway
AT kuanwang thyroidhormoneinducesoralcancergrowthviathepdl1dependentsignalingpathway